ClinicalTrials.Veeva

Menu
C

Clinical Site Partners, LLC | Florida Pulmonary Research Institute, LLC

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

TAK-925
Ensifentrine
Zinpentraxin Alfa
BI 690517
TAK-994
Lebrikizumab
PF-03715455
BIO-11006
YPL-001
RPL554

Parent organization

This site is a part of Clinical Site Partners, LLC

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 20 total trials

A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis

A randomized, double-blind, placebo-controlled clinical study to evaluate the safety and efficacy of 2 doses of inhaled pirfenidone (AP01) versus pla...

Enrolling
Progressive Pulmonary Fibrosis
Drug: AP01
Other: Placebo

The main purpose of this first-in-human study is to generate sufficient safety and immunogenicity data to enable the selection of an appropriate dose...

Active, not recruiting
Herpes Zoster
Biological: Placebo
Biological: mRNA-1468

This study is open to adults aged 18 or above legal age with heart failure. People can join the study if they have heart failure symptoms and a left...

Enrolling
Heart Failure
Drug: BI 690517
Drug: Empagliflozin

The purpose of this clinical trial is to learn about the safety, pharmacokinetics (pharmacokinetics helps us understand how the drug is changed and e...

Enrolling
COVID-19
Drug: nirmatrelvir
Drug: ritonavir

Efficacy Study: This randomized, double-blinded, placebo-controlled Phase 3 study is designed to assess the safety, immunogenicity, and efficacy of a...

Active, not recruiting
Lower Respiratory Tract Illness
Biological: RSVpreF
Biological: Placebo

Trial sponsors

Pfizer logo
Genentech logo
M
Roche logo
V
A
B
Boehringer Ingelheim logo
Exact Sciences Corporation logo
Innovent Biologics logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems